Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 Recruiting Phase 1 Trials for Sonidegib (DB09143)

IndicationStatusPhase
DBCOND0113388 (Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04007744Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid TumorsTreatment